Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript
Source: SeekingAlpha
2025-11-03 21:36:24 ET
Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases November 3, 2025 4:15 PM EST...
Read the full article on Seeking Alpha
For further details see:
Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript
Connect Biopharma Holdings Limited
NASDAQ: CNTB
CNTB Trading
4.21% G/L:
$2.60 Last:
148,816 Volume:
$2.52 Open:
CNTB Latest News
March 03, 2026 09:00:00 am
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
February 19, 2026 09:00:00 am
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
January 12, 2026 08:00:00 am
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
CNTB Stock Data
$149,262,380
15,429,370
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
CN
San Diego
